This article looks at some of the key legal and practical issues surrounding the competition authorities' review of mergers in the pharmaceutical sector in Turkey, including review triggers and thresholds.
Will The Treatment Of Selective Distribution Systems Ever Be The Same Again? The Turkish Competition Board s Johnson&Johnson Decision - Anti-trust/Competition Law mondaq.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mondaq.com Daily Mail and Mail on Sunday newspapers.
To print this article, all you need is to be registered or login on Mondaq.com.
Introduction Johnson&Johnson ) applied
in June 2019 to the Turkish Competition Authority
(
TCA ) and asked the
Competition Board (
Board ) to
assess whether Johnson&Johnson s contemplated Warehouse
Sale Agreement for Human Medicine
(
Agreement ) falls within the
protective cloak of the Block Exemption Communiqué No.
2002/2 on Vertical Agreements (
Communiqué
No. 2002/2 ) or, if not, satisfies the
conditions for an individual exemption as per Article 5 of the Law
No. 4054 on the Protection of the Competition
(
Law No. 4054 ).
The Agreement sought to establish a quantitative
1
selective distribution system whereby nine pharmaceutical